Aquatic Capital Management LLC Has $504,000 Stock Holdings in Establishment Labs Holdings Inc. (NASDAQ:ESTA)

Aquatic Capital Management LLC increased its holdings in Establishment Labs Holdings Inc. (NASDAQ:ESTA) by 173.4% in the 4th quarter, Holdings Channel reports. The fund owned 10,934 shares of the company’s stock after purchasing an additional 6,934 shares during the period. Aquatic Capital Management LLC’s holdings in Establishment Labs were worth $504,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of the business. R Squared Ltd purchased a new stake in shares of Establishment Labs in the fourth quarter worth approximately $36,000. KLP Kapitalforvaltning AS acquired a new position in Establishment Labs in the 4th quarter valued at approximately $161,000. Hood River Capital Management LLC lifted its position in Establishment Labs by 236.4% in the 4th quarter. Hood River Capital Management LLC now owns 5,920 shares of the company’s stock worth $273,000 after buying an additional 4,160 shares in the last quarter. Handelsbanken Fonder AB boosted its stake in shares of Establishment Labs by 32.3% during the 4th quarter. Handelsbanken Fonder AB now owns 8,200 shares of the company’s stock valued at $378,000 after buying an additional 2,000 shares during the period. Finally, Nebula Research & Development LLC purchased a new position in shares of Establishment Labs during the 4th quarter valued at $440,000. 72.91% of the stock is currently owned by institutional investors and hedge funds.

Establishment Labs Trading Up 2.3 %

Establishment Labs stock opened at $31.04 on Friday. Establishment Labs Holdings Inc. has a one year low of $26.56 and a one year high of $60.12. The company’s fifty day moving average price is $35.72 and its two-hundred day moving average price is $38.94. The company has a market capitalization of $895.38 million, a price-to-earnings ratio of -12.03 and a beta of 0.77. The company has a debt-to-equity ratio of 5.94, a current ratio of 3.62 and a quick ratio of 2.29.

Establishment Labs (NASDAQ:ESTA) last issued its quarterly earnings data on Wednesday, February 26th. The company reported ($0.98) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.64) by ($0.34). The company had revenue of $44.51 million during the quarter, compared to the consensus estimate of $44.45 million. Establishment Labs had a negative net margin of 46.13% and a negative return on equity of 184.55%. On average, analysts forecast that Establishment Labs Holdings Inc. will post -2.41 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several brokerages recently issued reports on ESTA. Needham & Company LLC began coverage on Establishment Labs in a report on Monday, April 14th. They set a “hold” rating for the company. Stephens reaffirmed an “overweight” rating and set a $52.00 price target on shares of Establishment Labs in a research note on Thursday, March 6th. Two equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $57.40.

Establishment Labs Company Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.